arrow
D

D. Marshall Brinkley

Vanderbilt University Medical Center
H指数:20
被引数:2,273

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dynamic cellular programs of human cardiac allograft rejection revealed by spatial transcriptomics

利用空间转录组学揭示的人类心脏移植排斥反应的动态细胞程序

2026-08-100
OA
Elevated oxygen extraction during heart transplantation is associated with increased morbidity and mortality: Implications for goal-directed perfusion

心脏移植期间升高的氧摄取与增加的发病率和死亡率相关:对目标导向灌注的启示

2026-02-010
OAAI
Cardiovascular-Kidney-Metabolic Disease Burden in Children and Adults Following Heart Transplantation

心脏移植后儿童与成人心血管-肾脏-代谢疾病负担

2025-10-200
OAAI
Two hundred cases of cardiac donation after circulatory death utilizing normothermic regional perfusion: The 4-year Vanderbilt experience
2025-10-011
OAAI
10-minute Asystolic Warm Ischemic Time (AWIT) Predicts Mortality and Severe Primary Graft Dysfunction in Donation After Circulatory Death Hearts Recovered With Thoracoabdominal Normothermic Regional Perfusion

10分钟停搏热缺血时间(AWIT)可预测循环死亡后心脏捐赠中经胸腹常温区域性灌注复苏心脏的死亡率和严重原发性移植物功能障碍。

2025-07-210
PRE
Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial

心脏生物标志物及阿非卡坦在梗阻性肥厚型心肌病中的疗效:SEQUOIA-HCM试验

2024-09-013
OAAI
Denial for Advanced Heart Failure Therapies Due to Psychosocial Stressors: Who Comes Back?

因心理社会压力因素拒绝接受先进心力衰竭疗法:谁会回来?

2024-09-010
PRE
CARDIAC DONATION AFTER CIRCULATORY DEATH UTILIZING NORMOTHERMIC REGIONAL PERFUSION: THE THREE-YEAR VANDERBILT EXPERIENCE (vol 43, S121, 2024)
2024-08-010
OAAI
Early Assessment of Cardiac Allograft Vasculopathy Risk Among Recipients of Hepatitis C Virus-infected Donors in the Current Era
2024-05-011
PRE
The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared With Outpatients With HFrEF: An Analysis of GALACTIC-HF
2024-01-010
OA